| Entry |
|
|---|
| Name |
Flopropione (JP18/INN);
Ephtanon (TN) |
|---|
| Formula |
C9H10O4
|
|---|
| Exact mass |
182.0579
|
|---|
| Mol weight |
182.17
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01497 Catechol O-methyltransferase inhibitor
|
|---|
| Remark |
| Therapeutic category: | 1249 |
|
|---|
| Efficacy |
Antispasmodic, Cathechol-O-methyltransferase (COMT) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
124 Antispasmodics
1249 Others
D01259 Flopropione (JP18/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01497 Catechol O-methyltransferase inhibitor
D01259 Flopropione
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
COMT
D01259 Flopropione (JP18/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01259 Flopropione
D01259 Flopropione capsules
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C8y C 21.6504 -17.4084
2 C8x C 21.6504 -18.8086
3 C8y C 22.8659 -19.5087
4 C8x C 24.0743 -18.8086
5 C8y C 24.0743 -17.4084
6 C8y C 22.8659 -16.7083
7 O1a O 20.4382 -16.7077
8 O1a O 25.2874 -16.7092
9 O1a O 22.8676 -20.9088
10 C5a C 22.8676 -15.3082
11 C1b C 24.0811 -14.6096
12 O5a O 21.6560 -14.6066
13 C1a C 25.2929 -15.3112
BOND 13
1 1 7 1
2 1 2 2
3 5 8 1
4 2 3 1
5 3 9 1
6 3 4 2
7 6 10 1
8 4 5 1
9 10 11 1
10 5 6 2
11 10 12 2
12 6 1 1
13 11 13 1
|
|---|
